Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

DSM-Firmenich (DSMN.AS)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (€)	Price Target (€)	Rating
2020-01-17	110.50	126.00	Buy
2020-04-09	107.55	118.00	Buy
2020-05-08	114.90	125.00	Buy
2020-07-08	125.50	138.00	Buy
2020-08-21	132.10	150.00	Buy
2020-10-07	143.95	160.00	Buy
2021-02-17	145.75	165.00	Buy
2021-05-06	154.45	170.00	Buy
2021-07-14	161.25	175.00	Buy
2021-08-24	181.70	200.00	Buy
2022-01-18	176.70	205.00	Buy
2022-02-16	164.75	190.00	Buy
2022-03-30	162.80	185.00	Buy
2022-05-04	153.30	180.00	Buy
2022-07-14	141.55	166.00	Buy
2022-08-03	146.05	170.00	Buy
2022-10-03	118.60	155.00	Buy
2022-11-02	113.75	145.00	Buy
2022-12-13	124.80	143.00	Buy
2023-01-06	121.00	140.00	Buy
2023-03-24	109.20	137.00	Buy

Disclosures

Within the past 12 months, UBS Securities LLC and/or its affiliates have received compensation for products and services other than investment banking services from this company/entity.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.